These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33358507)

  • 1. [Hepatitis B vaccine and liver cancer].
    Lebossé F; Zoulim F
    Bull Cancer; 2021 Jan; 108(1):90-101. PubMed ID: 33358507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B vaccination in children: the Taiwan experience.
    Ni YH; Chen DS
    Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term Effects of Hepatitis B Immunization of Infants in Preventing Liver Cancer.
    Chang MH; You SL; Chen CJ; Liu CJ; Lai MW; Wu TC; Wu SF; Lee CM; Yang SS; Chu HC; Wang TE; Chen BW; Chuang WL; Soon MS; Lin CY; Chiou ST; Kuo HS; Chen DS;
    Gastroenterology; 2016 Sep; 151(3):472-480.e1. PubMed ID: 27269245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B vaccination and prevention of hepatocellular carcinoma.
    Kao JH
    Best Pract Res Clin Gastroenterol; 2015 Dec; 29(6):907-17. PubMed ID: 26651252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer prevention by vaccination against hepatitis B.
    Chang MH
    Recent Results Cancer Res; 2009; 181():85-94. PubMed ID: 19213561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of hepatitis B vaccination on hepatitis B prevention and on hepatocellular carcinoma].
    Li RC; Yang JY; Gong J; Li YP; Huang ZN; Fang KX; Xu ZY; Liu CB; Zhao K; Zhuang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):385-7. PubMed ID: 15231157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of hepatocellular carcinoma in hepatitis B virus infection.
    Lim SG; Mohammed R; Yuen MF; Kao JH
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1352-7. PubMed ID: 19702903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Universal HBV vaccination dramatically reduces the prevalence of HBV infection and incidence of hepatocellular carcinoma.
    Wong GL; Hui VW; Yip TC; Liang LY; Zhang X; Tse YK; Lai JC; Chan HL; Wong VW
    Aliment Pharmacol Ther; 2022 Sep; 56(5):869-877. PubMed ID: 35864571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does anti-hepatitis B virus vaccine make any difference in long-term number of liver transplantation?
    Chaib E; Coimbra BG; Galvão FH; Tatebe ER; Shinzato MS; D'Albuquerque LA; Massad E
    Clin Transplant; 2012; 26(6):E590-5. PubMed ID: 23083337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch-up immunization program.
    McMahon BJ; Bulkow LR; Singleton RJ; Williams J; Snowball M; Homan C; Parkinson AJ
    Hepatology; 2011 Sep; 54(3):801-7. PubMed ID: 21618565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B: Immunization and Impact on Natural History and Cancer Incidence.
    Lin CL; Kao JH
    Gastroenterol Clin North Am; 2020 Jun; 49(2):201-214. PubMed ID: 32389359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatocellular carcinoma, hepatitis B virus and the immune system].
    Grob PJ
    Schweiz Med Wochenschr; 1986 Aug; 116(34):1133-45. PubMed ID: 3020684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primary prevention by hepatitis B vaccine on liver cancer in high incidence area of China].
    Wang YT; Chen TY; Zhu J; Jiao YC; Qu CF
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Apr; 52(4):402-408. PubMed ID: 29614608
    [No Abstract]   [Full Text] [Related]  

  • 14. The immunogenicity of GSK's recombinant hepatitis B vaccine in children: a systematic review of 30 years of experience.
    van den Ende C; Marano C; van Ahee A; Bunge EM; De Moerlooze L
    Expert Rev Vaccines; 2017 Aug; 16(8):789-809. PubMed ID: 28586278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral hepatitis and hepatocellular carcinoma prevention strategy in Japan.
    Oda T
    Jpn J Cancer Res; 1999 Oct; 90(10):1051-60. PubMed ID: 10595731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary and secondary prevention of liver cancer caused by HBV.
    Blumberg BS
    Front Biosci (Schol Ed); 2010 Jan; 2(2):756-63. PubMed ID: 20036981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: the prevention of hepatitis B-related hepatocellular carcinoma.
    Lin CL; Kao JH
    Aliment Pharmacol Ther; 2018 Jul; 48(1):5-14. PubMed ID: 29722445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus and cancer prevention.
    Chang MH
    Recent Results Cancer Res; 2011; 188():75-84. PubMed ID: 21253790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of hepatocellular carcinoma in childhood after introduction of selective vaccination against hepatitis B virus for infants born to HBV carrier mothers.
    Tajiri H; Tanaka H; Brooks S; Takano T
    Cancer Causes Control; 2011 Mar; 22(3):523-7. PubMed ID: 21191808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study.
    Chang MH; You SL; Chen CJ; Liu CJ; Lee CM; Lin SM; Chu HC; Wu TC; Yang SS; Kuo HS; Chen DS;
    J Natl Cancer Inst; 2009 Oct; 101(19):1348-55. PubMed ID: 19759364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.